Published in Neurosci Biobehav Rev on April 07, 2015
Longitudinal Assessment of Neurocognitive Outcomes in Survivors of Childhood Acute Lymphoblastic Leukemia Treated on a Contemporary Chemotherapy Protocol. J Clin Oncol (2016) 0.80
Health-related Quality of Life (HR-QOL) and Chronic Health Conditions in Survivors of Childhood Acute Myeloid Leukemia (AML) with Down Syndrome (DS): A Report From the Children's Oncology Group. J Pediatr Hematol Oncol (2016) 0.75
Declines Noted in Cognitive Processes and Association With Achievement Among Children With Leukemia. Oncol Nurs Forum (2017) 0.75
Cognitive, behaviour, and academic functioning in adolescent and young adult survivors of childhood acute lymphoblastic leukaemia: a report from the Childhood Cancer Survivor Study. Lancet Psychiatry (2016) 0.75
Leukoencephalopathy and long-term neurobehavioural, neurocognitive, and brain imaging outcomes in survivors of childhood acute lymphoblastic leukaemia treated with chemotherapy: a longitudinal analysis. Lancet Haematol (2016) 0.75
Feasibility of baseline neurocognitive assessment using Cogstate during the first month of therapy for childhood leukemia. Support Care Cancer (2016) 0.75
What is known and unknown about chemotherapy-related cognitive impairment in patients with haematological malignancies and areas of needed research. Br J Haematol (2016) 0.75
Effect of methotrexate/vitamin B12 on DNA methylation as a potential factor in leukemia treatment-related neurotoxicity. Epigenomics (2017) 0.75
Treating childhood acute lymphoblastic leukemia without cranial irradiation. N Engl J Med (2009) 7.95
Development of risk-based guidelines for pediatric cancer survivors: the Children's Oncology Group Long-Term Follow-Up Guidelines from the Children's Oncology Group Late Effects Committee and Nursing Discipline. J Clin Oncol (2004) 4.63
Improved outcome for children with acute lymphoblastic leukemia: results of Total Therapy Study XIIIB at St Jude Children's Research Hospital. Blood (2004) 4.21
Clinical ascertainment of health outcomes among adults treated for childhood cancer. JAMA (2013) 3.65
Epidemiology of childhood cancer. Cancer Treat Rev (2010) 3.32
Cytokines and their relationship to the symptoms and outcome of cancer. Nat Rev Cancer (2008) 2.89
Cytokines and cognition--the case for a head-to-toe inflammatory paradigm. J Am Geriatr Soc (2002) 2.79
Long-term results of the children's cancer group studies for childhood acute lymphoblastic leukemia 1983-2002: a Children's Oncology Group Report. Leukemia (2009) 2.58
Doxorubicin-induced cardiomyopathy: from molecular mechanisms to therapeutic strategies. J Mol Cell Cardiol (2012) 2.56
Comparison of long-term neurocognitive outcomes in young children with acute lymphoblastic leukemia treated with cranial radiation or high-dose or very high-dose intravenous methotrexate. J Clin Oncol (2006) 2.19
Environmental risk factors for attention-deficit hyperactivity disorder. Acta Paediatr (2007) 2.10
Neurocognitive functioning in adult survivors of childhood non-central nervous system cancers. J Natl Cancer Inst (2010) 1.83
Neurocognitive outcomes decades after treatment for childhood acute lymphoblastic leukemia: a report from the St Jude lifetime cohort study. J Clin Oncol (2013) 1.76
Homocysteine, pharmacogenetics, and neurotoxicity in children with leukemia. J Clin Oncol (2003) 1.75
Accelerated aging, decreased white matter integrity, and associated neuropsychological dysfunction 25 years after pediatric lymphoid malignancies. J Clin Oncol (2013) 1.67
Long-term follow-up care for pediatric cancer survivors. Pediatrics (2009) 1.63
Methylenetetrahydrofolate reductase (MTHFR) genetic polymorphisms and psychiatric disorders: a HuGE review. Am J Epidemiol (2006) 1.63
Early intensification of intrathecal chemotherapy virtually eliminates central nervous system relapse in children with acute lymphoblastic leukemia. Blood (1998) 1.60
CNS late-effects after ALL therapy in childhood. Part III: neuropsychological performance in long-term survivors of childhood ALL: impairments of concentration, attention, and memory. Med Pediatr Oncol (2002) 1.55
Risk of late effects of treatment in children newly diagnosed with standard-risk acute lymphoblastic leukaemia: a report from the Childhood Cancer Survivor Study cohort. Lancet Oncol (2014) 1.53
Fatigue and sleep disturbance in adult survivors of childhood cancer: a report from the childhood cancer survivor study (CCSS). Sleep (2008) 1.50
Prevalence of leukoencephalopathy in children treated for acute lymphoblastic leukemia with high-dose methotrexate. AJNR Am J Neuroradiol (2005) 1.48
Biology and treatment of infant leukemias. Leukemia (1995) 1.44
Genetic polymorphisms in monoamine systems and outcome of cognitive behavior therapy for social anxiety disorder. PLoS One (2013) 1.44
Cognitive outcomes following contemporary treatment without cranial irradiation for childhood acute lymphoblastic leukemia. J Natl Cancer Inst (2012) 1.41
Health-related quality of life among child and adolescent survivors of childhood cancer. J Clin Oncol (2006) 1.36
Parent distress in childhood cancer: a comparative evaluation of posttraumatic stress symptoms, depression and anxiety. Acta Oncol (2008) 1.32
White matter fractional anisotropy correlates with speed of processing and motor speed in young childhood cancer survivors. Int J Radiat Oncol Biol Phys (2008) 1.30
Prevalence and correlates of fatigue in long-term survivors of childhood leukemia. J Clin Oncol (2005) 1.26
Gene-environment interplay in internalizing disorders: consistent findings across six environmental risk factors. J Child Psychol Psychiatry (2009) 1.19
Increased risk of vincristine neurotoxicity associated with low CYP3A5 expression genotype in children with acute lymphoblastic leukemia. Pediatr Blood Cancer (2010) 1.18
Elevation of homocysteine and excitatory amino acid neurotransmitters in the CSF of children who receive methotrexate for the treatment of cancer. J Clin Oncol (1997) 1.17
Neurocognitive function and CNS integrity in adult survivors of childhood hodgkin lymphoma. J Clin Oncol (2012) 1.16
Slight cognitive impairment and magnetic resonance imaging abnormalities but normal school levels in children treated for acute lymphoblastic leukemia with chemotherapy only. J Pediatr (2001) 1.14
Gene-environment interaction. Annu Rev Psychol (2014) 1.12
Methotrexate-induced neurotoxicity and leukoencephalopathy in childhood acute lymphoblastic leukemia. J Clin Oncol (2014) 1.10
Effect of azole antifungal therapy on vincristine toxicity in childhood acute lymphoblastic leukaemia. J Antimicrob Chemother (2011) 1.10
Genetic mediators of neurocognitive outcomes in survivors of childhood acute lymphoblastic leukemia. J Clin Oncol (2013) 1.10
Deficiency of asparagine synthetase causes congenital microcephaly and a progressive form of encephalopathy. Neuron (2013) 1.06
Impact of methylenetetrahydrofolate reductase (MTHFR) polymorphisms on methotrexate-induced toxicities in acute lymphoblastic leukemia: a meta-analysis. Tumour Biol (2012) 1.04
Oxidative stress and executive function in children receiving chemotherapy for acute lymphoblastic leukemia. Pediatr Blood Cancer (2009) 1.02
Direct effects of doxorubicin on skeletal muscle contribute to fatigue. Br J Cancer (2009) 1.02
Health-related quality of life, lifestyle behaviors, and intervention preferences of survivors of childhood cancer. J Cancer Surviv (2013) 1.01
Working memory in survivors of childhood acute lymphocytic leukemia: functional neuroimaging analyses. Pediatr Blood Cancer (2010) 1.00
Longitudinal patterns of psychological distress in adult survivors of childhood cancer. Br J Cancer (2013) 0.99
A systematic review of studies on psychosocial late effects of childhood cancer: structures of society and methodological pitfalls may challenge the conclusions. Pediatr Blood Cancer (2010) 0.98
Fatigue, vitality, sleep, and neurocognitive functioning in adult survivors of childhood cancer: a report from the Childhood Cancer Survivor Study. Cancer (2011) 0.97
Symptoms of attention-deficit/hyperactivity disorder in long-term survivors of childhood leukemia. Pediatr Blood Cancer (2011) 0.96
Visuomotor control in survivors of childhood acute lymphoblastic leukemia treated with chemotherapy only. J Int Neuropsychol Soc (2005) 0.95
Contribution of diet and physical activity to metabolic parameters among survivors of childhood leukemia. Cancer Causes Control (2012) 0.95
Toward optimal central nervous system-directed treatment in childhood acute lymphoblastic leukemia. J Clin Oncol (2003) 0.94
Polymorphisms of genes controlling homocysteine levels and IQ score following the treatment for childhood ALL. Pharmacogenomics (2005) 0.94
Psychiatric adverse effects of pediatric corticosteroid use. Mayo Clin Proc (2014) 0.94
Oxidative stress and neurobehavioral problems in pediatric acute lymphoblastic leukemia patients undergoing chemotherapy. J Pediatr Hematol Oncol (2010) 0.94
The impact of therapy for childhood acute lymphoblastic leukaemia on intelligence quotients; results of the risk-stratified randomized central nervous system treatment trial MRC UKALL XI. J Hematol Oncol (2011) 0.93
Association between the prevalence of symptoms and health-related quality of life in adult survivors of childhood cancer: a report from the St Jude Lifetime Cohort study. J Clin Oncol (2013) 0.92
Sleep, fatigue, depression, and quality of life in survivors of childhood acute lymphoblastic leukemia. Pediatr Blood Cancer (2012) 0.92
Plasma homocysteine in children with acute lymphoblastic leukemia: changes during a chemotherapeutic regimen including methotrexate. Cancer Res (1991) 0.91
Motor and perceptual timing deficits among survivors of childhood leukemia. J Pediatr Psychol (2007) 0.91
Dexamethasone exposure and memory function in adult survivors of childhood acute lymphoblastic leukemia: A report from the SJLIFE cohort. Pediatr Blood Cancer (2013) 0.90
Polymorphisms in genes involved in the corticosteroid response and the outcome of childhood acute lymphoblastic leukemia. Am J Pharmacogenomics (2004) 0.88
Diffusion tensor imaging and neurocognition in survivors of childhood acute lymphoblastic leukaemia. Brain (2014) 0.88
Progressive neurocognitive impairment in young adult survivors of childhood acute lymphoblastic leukemia. Pediatr Blood Cancer (2009) 0.87
History of the treatment of childhood ALL: a paradigm for cancer cure. Best Pract Res Clin Haematol (2006) 0.87
Risk assessment of drug interaction potential and concomitant dosing pattern on targeted toxicities in pediatric cancer patients. AAPS J (2013) 0.86
Concentration of IL-2, IL-6, IL-8, IL-10 and TNF-alpha in children with acute lymphoblastic leukemia after cessation of chemotherapy. Hematol Oncol (2004) 0.84
Corticosteroids, behavior, and quality of life in children treated for acute lymphoblastic leukemia; a multicentered trial. J Pediatr Hematol Oncol (2012) 0.84
Population PK/PD model of homocysteine concentrations after high-dose methotrexate treatment in patients with acute lymphoblastic leukemia. PLoS One (2012) 0.84
Almost normal cognitive function in patients during therapy for childhood acute lymphoblastic leukemia without cranial irradiation according to ALL-BFM 95 and COALL 06-97 protocols: results of an Austrian-German multicenter longitudinal study and implications for follow-up. Pediatr Hematol Oncol (2007) 0.83
Neurochemical markers of brain damage in cerebrospinal fluid during induction treatment of acute lymphoblastic leukemia in children. Pediatr Blood Cancer (2008) 0.83
Drug interactions in childhood cancer. Lancet Oncol (2010) 0.83
Neurocognitive outcome and white matter anisotropy in childhood acute lymphoblastic leukemia survivors treated with different protocols. Pediatr Hematol Oncol (2014) 0.82
Clinical pharmacogenetics of methotrexate. Curr Drug Metab (2011) 0.82
Impact of chemotherapy for childhood leukemia on brain morphology and function. PLoS One (2013) 0.82
Late effects in long-term survivors of ALL in childhood: experiences from the SPOG late effects study. Swiss Med Wkly (2001) 0.81
Children and adolescents coping with cancer: self- and parent reports of coping and anxiety/depression. Health Psychol (2014) 0.81
Long-term effects of cranial irradiation and intrathecal chemotherapy in treatment of childhood leukemia: a MEG study of power spectrum and correlated cognitive dysfunction. BMC Neurol (2012) 0.81
Parental needs for information related to neurocognitive late effects from pediatric cancer and its treatment. Pediatr Blood Cancer (2009) 0.80
Methylenetetrahydrofolate reductase gene polymorphisms in children with attention deficit hyperactivity disorder. Int J Med Sci (2011) 0.79
Post-traumatic stress symptoms among mothers of children with leukemia undergoing treatment: a longitudinal study. Psychooncology (2012) 0.79
Cerebrospinal fluid IL-6, TNF-α and MCP-1 in children with acute lymphoblastic leukaemia during chemotherapy. Neuropediatrics (2011) 0.79
Emotional regulation and adjustment to childhood cancer: role of the biological, psychological and social regulators on pediatric oncology adjustment. Iran J Cancer Prev (2013) 0.79
Motor performance and functional exercise capacity in survivors of pediatric acute lymphoblastic leukemia. Pediatr Blood Cancer (2012) 0.78
Does dexamethasone induce more neuropsychological side effects than prednisone in pediatric acute lymphoblastic leukemia? A systematic review. Pediatr Blood Cancer (2014) 0.78
Hypothalamic-pituitary-adrenal axis function in survivors of childhood acute lymphoblastic leukemia and healthy controls. Psychoneuroendocrinology (2012) 0.78
MRI morphometric and neuropsychological correlates of long-term memory in survivors of childhood leukemia. Pediatr Blood Cancer (2004) 0.78
Longitudinal psychosocial outcomes in two cohorts of adult survivors from childhood acute leukemia treated with or without cranial radiation. Minerva Pediatr (2006) 0.78
Parent perceptions of managing child behavioural side-effects of cancer treatment: a qualitative study. Child Care Health Dev (2014) 0.77
Role of NOS3 DNA variants in externalizing behavioral problems observed in childhood leukemia survivors. J Pediatr Hematol Oncol (2013) 0.77
Behavioral side effects of pediatric acute lymphoblastic leukemia treatment: the role of parenting strategies. Pediatr Blood Cancer (2014) 0.77
Cerebral venous sinus thrombosis in pediatric cancer patients: long-term neurological outcomes. J Pediatr Hematol Oncol (2013) 0.76
Azole interactions with multidrug therapy in pediatric oncology. Eur J Clin Pharmacol (2012) 0.76
A pilot study on the contribution of folate gene variants in the cognitive function of ADHD probands. Neurochem Res (2014) 0.76
Indices of language outcome 11 years after intrathecal chemotherapy for acute lymphoblastic leukemia: a sibling case-control study. Pediatr Hematol Oncol (2012) 0.76
Longitudinal language outcomes following intrathecal chemotherapy for acute lymphoblastic leukaemia. Int J Speech Lang Pathol (2012) 0.76
Intellectual functioning of childhood leukemia survivors--relation to Tau protein--a marker of white matter injury. Adv Med Sci (2012) 0.75
Child-rearing in the context of childhood cancer: perspectives of parents and professionals. Pediatr Blood Cancer (2013) 0.75